STOCK TITAN

USANA (USNA) chief people officer sells 5,561 shares, exits stake

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

USANA Health Sciences chief people officer Paul A. Jones sold 5,561 shares of company common stock in an open-market transaction at $18.50 per share. Following this sale, he reported holding no shares of USANA common stock directly.

Positive

  • None.

Negative

  • None.
Insider Jones Paul A.
Role CHIEF PEOPLE OFFICER
Sold 5,561 shs ($103K)
Type Security Shares Price Value
Sale Common Stock 5,561 $18.50 $103K
Holdings After Transaction: Common Stock — 0 shares (Direct, null)
Footnotes (1)
Shares sold 5,561 shares Open-market sale of USANA common stock
Sale price per share $18.50 per share Price for the 5,561-share open-market sale
Net shares sold 5,561 shares Net share change from this Form 4 transaction
Shares held after sale 0 shares Total directly held USANA common stock after transaction
open-market sale financial
"transaction_action is described as an open-market sale of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"security_title for the transaction is listed as Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) describes this insider transaction"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction code "S" financial
"the filing uses transaction code "S" for this sale"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did USANA (USNA) report for Paul A. Jones?

USANA reported that chief people officer Paul A. Jones executed an open-market sale of company common stock. He sold 5,561 shares in a single transaction, as disclosed in the Form 4 insider trading report filed with regulators.

How many USANA (USNA) shares did Paul A. Jones sell and at what price?

Paul A. Jones sold 5,561 shares of USANA common stock at a price of $18.50 per share. This transaction was an open-market sale and is reported as a single non-derivative transaction on the Form 4.

What is Paul A. Jones’s role at USANA (USNA) in this Form 4 filing?

In this Form 4 filing, Paul A. Jones is identified as an officer of USANA Health Sciences, serving as chief people officer. The reported transaction reflects his activity in the company’s common stock as an executive insider.

How many USANA (USNA) shares does Paul A. Jones hold after the sale?

After selling 5,561 shares of USANA common stock, Paul A. Jones reported owning zero shares directly. The Form 4 shows total shares following the transaction as 0.0000, indicating no remaining directly held common stock.

Was the USANA (USNA) insider transaction by Paul A. Jones an open-market sale?

Yes. The Form 4 describes the transaction as an open-market sale of USANA common stock. It uses transaction code “S” and explicitly labels the transaction action as an open-market sale at $18.50 per share for all 5,561 shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jones Paul A.

(Last)(First)(Middle)
3838 WEST PARKWAY BLVD.

(Street)
SALT LAKE CITY UTAH 84120

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF PEOPLE OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/08/2026S5,561D$18.50D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)